Home > Browse Research > Life Sciences > Diagnostics

Diagnostics: market research reports

Diagnostics refers to the investigation and identification of disease states in medicine. The modern diagnostic industry generally falls into two broad categories: in vitro diagnostics (from the Latin meaning "in glass") and in vivo diagnostics (from the Latin meaning "in the living"). In vitro diagnostics involves the removal samples of tissue such as blood, saliva, biopsy samples from a living organism for examination in the laboratory setting, whereas in vivo diagnostics involves observing and testing tissue and function in a living organism—techniques such as medical imaging (x-rays, magnetic resonance, computed tomography, etc.) and monitoring like electrocardiography, electroencephalography, etc.).

The in vitro diagnostics industry is a near $50 billion sector that includes the manufacture of tests ranging from over-the-counter at-home kits, such as pregnancy tests, to highly sophisticated molecular (or nucleic acid) tests. In addition to the test elements (the reagents), the laboratory market that the IVD industry serves also includes sales of the equipment used to handle and analyze results. These systems include automated and high-throughput analyzers and readers to assist in handling the large volume of tests that typical hospitals and reference labs.
The medical imaging sector is a technology-intensive area of diagnostics that has traditionally been consolidated in the hands of a few large corporations. The sector is driven by innovation in both equipment (miniaturization, portability, integration with IT infrastructures) and in clinical and research application. Improvements in computer enhancement and in new contrast media as well as the advent of high-tech molecular imaging techniques has broadened the range of conditions that in vivo imaging can address.

Diagnostics Company Reports (1137)

In Vitro Diagnostics (3046)

Blood Banking & Tissue Typing (261)
Cardiovascular (59)
Clinical Chemistry (259)
Clinical Laboratory Automation (5)
Clinical Laboratory Instrumentation (37)
Coagulation (340)
Companion Diagnostics (26)
General In Vitro Diagnostics (625)
Hematology & Oncology (508)
Histology & Cytology (310)
More...

Medical Imaging (1549)

Computed Tomography (CT) (229)
Contrast Media (35)
Digital Radiography (25)
General Medical Imaging (57)
Interventional Radiology (22)
Mammography (109)
NMR & MRI (264)
Nuclear Medicine (186)
PACS (Picture Archiving Computer Systems) (98)
PET (Positron Emission Tomography) (32)
More...

Regulation (5)

Diagnostics market research reports and industry analysis

Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) 6/13/2013 \| published by: Renub Research ... as well and slowly becoming the reality of future in the diagnostics industry By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 ... \| read more...	$1,400.00
Global Database of the Top In-Vitro Diagnostic Substance Producers - Company Names, Financial Performance, Key Executives, and Contact Details 6/10/2013 \| published by: Global Research & Data Services ... the world. The report includes details for more than 550 in-vitro diagnostic substance producers in the world which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other ... \| read more...	$782.00
2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Italy: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Japan: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,750.00
2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$3,500.00
Bioinformatics in IVD Testing 6/7/2013 \| published by: Kalorama Information ... test interpretation. This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact. Bioinformatics-based testing has made a huge contribution to cancer diagnosis ... \| read more...	$1,995.00
2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers 6/7/2013 \| published by: Venture Planning Group ... 2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, ... \| read more...	$6,500.00
2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines,, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in the UK: Hospitals and Commercial Labs 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$6,500.00
2013 Endocrine Function Testing Market in Italy: Hospitals and Commercial Labs 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$3,500.00
Companion Diagnostics Market, 2012-2023 6/6/2013 \| published by: Roots Analysis Pvt. Ltd. ... potential abnormalities and tailoring the treatment so as to make it as individualised as the disease itself. Targeted drugs have been fast to overshadow the traditional drugs, which favour the concept of one-size-fits-all. This has ... \| read more...	$1,699.00
2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in Japan: Hospitals and Commercial Labs 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,750.00
2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$6,500.00
2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Germany: Hospitals, Commercial Labs, Physician Offices 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Japan: Hospitals and Commercial Labs 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$2,750.00

< prev 1 2 3 4 5 6 7 8 9 10 next >